Aspiration of metrizamide following lumbar myelography.
When metrizamide was aspirated at the termination of lumbar myelography in 117 patients, 20% complained of a headache and 9% complained of nausea. There were no episodes of seizures. Chemical analysis of aspirated cerebrospinal fluid showed that 66% of the injected contrast material was recovered. Little additional effort is required to reduce the incidence of minor but frequent adverse reactions to metrizamide myelography.
D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D008793:Metrizamide / Q000009:adverse effects*; D009192:Myelography / Q000379:methods*; D013396:Suction
D003287:Contrast Media; D008793:Metrizamide